Surmodics | SRDX - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Abbott USD 6.8B 1.72B 2026-03
Align Technology USD 1.09B 90.32M 2025-12
Anika Therapeutics USD 41.02M 16.46M 2026-03
Arrowhead Research USD 201.64M 112.94M 2025-12
Artivion USD 64.91M 8.52M 2025-12
Baxter International USD 2.02B 51M 2026-03
Boston Scientific USD 1.45B 512M 2026-03
EDAP TMS EUR 29.84M 4.35M 2024-12
Edwards Lifesciences USD 2.4B 538M 2026-03
Haemonetics USD 363.37M 66.94M 2025-12
Heron Therapeutics USD 43.07M 26.55M 2025-09
J&J USD 21.69B 1.98B 2026-03
Merit Medical Systems USD 488.08M 41.68M 2026-03
Mesa Laboratories USD 28.98M 8.55M 2025-12
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Option Care Health USD 177.32M 55.3M 2026-03
Stryker USD 2.88B 1.13B 2026-03
Surmodics USD 36.11M 11.81M 2024-09
Trinity Biotech USD 1.34M 3.83M 2025-09